Please enable JavaScript to continue using this application.

Compare $CDNA vs $RCUS | Chartloom

Compare

$CDNA vs $RCUS

CareDx Inc · Arcus Biosciences Inc

CDNA

CareDx Inc

RCUS

Arcus Biosciences Inc

Compare $CDNA vs $RCUS

Comparing CareDx Inc and Arcus Biosciences Inc

CDNACareDx Inc

RCUSArcus Biosciences Inc

CDNACareDx Inc

Market cap

$3.29B

P/E (TTM)

30.64x

Forward P/E (NTM)

57.50x

Forward P/S (NTM)

6.55x

Rev growth (TTM)

34.4%

YTD performance

232.7%

52W performance

330.5%

FCF yield

2.6%

RCUSArcus Biosciences Inc

Market cap

$3.07B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

84.08x

Rev growth (TTM)

-55.3%

YTD performance

4.8%

52W performance

62.2%

FCF yield

-15.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CDNA

RCUS

Detailed metrics comparison

CDNA

CareDx Inc

RCUS

Arcus Biosciences Inc

Market Cap

CDNA$3.29B

RCUS$3.07B

Enterprise Value

CDNA$2.92B

RCUS$3.02B

Price

CDNA$63.67

RCUS$24.41

P/E Ratio

CDNA30.64x

RCUSN/A

P/S Ratio

CDNA7.18x

RCUS26.24x

EV/Sales

CDNA6.36x

RCUS25.82x

EV/EBITDA

CDNA23.24x

RCUS37.63x

P/B Ratio

CDNA8.16x

RCUS6.71x

P/FCF Ratio

CDNA39.14x

RCUSN/A

EV/FCF

CDNA34.70x

RCUS-6.36x

PEG Ratio

CDNA0.31x

RCUSN/A

Forward P/E (NTM)

CDNA57.50x

RCUSN/A

Forward P/S (NTM)

CDNA6.55x

RCUS84.08x

Revenue (TTM)

CDNA$458M

RCUS$117M

Revenue Growth (YoY)

CDNA34.4%

RCUS-55.3%

Forward Rev Growth

CDNA7.0%

RCUS-34.4%

Gross Margin (TTM)

CDNA70.6%

RCUS0.0%

Operating Margin (TTM)

CDNA23.6%

RCUS0.0%

EBITDA Margin (TTM)

CDNA27.4%

RCUS-406.8%

Net Margin (TTM)

CDNA24.2%

RCUS-393.2%

FCF Margin (TTM)

CDNA18.3%

RCUS-406.0%

Net Income (TTM)

CDNA$111M

RCUS$-460M

FCF (TTM)

CDNA$84M

RCUS$-475M

EPS (TTM)

CDNA$2.08

RCUS-$3.65

ROE (TTM)

CDNA32.8%

RCUS-8954.0%

ROA (TTM)

CDNA24.8%

RCUS-4561.0%

ROIC (TTM)

CDNA32.8%

RCUS-7501.0%

Cash

CDNA$374M

RCUS$150M

Debt

CDNA$0

RCUS$101M

Net Cash/Debt

CDNA$374M

RCUS$49M

Current Ratio (TTM)

CDNA4.58x

RCUS3.82x

Quick Ratio (TTM)

CDNA4.35x

RCUS3.75x

Debt/Equity (TTM)

CDNA0.00x

RCUS0.22x

Debt/Assets (TTM)

CDNA0.0%

RCUS0.0%

Interest Coverage (TTM)

CDNAN/A

RCUSN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

RCUS0.00x

Beta

CDNA2.58

RCUS1.05

52W Performance

CDNA330.5%

RCUS62.2%

YTD Performance

CDNA232.7%

RCUS4.8%

% from 52W High

CDNA-12.2%

RCUS-23.1%

% from 52W Low

CDNA356.4%

RCUS71.2%

Asset Turnover (TTM)

CDNA1.02x

RCUS0.12x

FCF Yield (TTM)

CDNA2.6%

RCUS-15.5%

Earnings Yield (TTM)

CDNA3.4%

RCUS-15.0%

Dividend Yield (TTM)

CDNAN/A

RCUSN/A

Rule of 40

CDNA52.7

RCUS-461.3

EV/GP/RG

CDNA0.94

RCUSN/A

Ticker research

View CDNA research View RCUS research

Metric	CDNA CareDx Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.29B	$3.07B
Enterprise Value	$2.92B	$3.02B
Price	$63.67	$24.41
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	26.24x
EV/Sales	6.36x	25.82x
EV/EBITDA	23.24x	37.63x
P/B Ratio	8.16x	6.71x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-6.36x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	N/A
Forward P/S (NTM)	6.55x	84.08x
Revenue & Growth
Revenue (TTM)	$458M	$117M
Revenue Growth (YoY)	34.4%	-55.3%
Forward Rev Growth	7.0%	-34.4%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-406.8%
Net Margin (TTM)	24.2%	-393.2%
FCF Margin (TTM)	18.3%	-406.0%
Net Income (TTM)	$111M	$-460M
FCF (TTM)	$84M	$-475M
EPS (TTM)	$2.08	-$3.65
ROE (TTM)	32.8%	-8954.0%
ROA (TTM)	24.8%	-4561.0%
ROIC (TTM)	32.8%	-7501.0%
Financial Health
Cash	$374M	$150M
Debt	$0	$101M
Net Cash/Debt	$374M	$49M
Current Ratio (TTM)	4.58x	3.82x
Quick Ratio (TTM)	4.35x	3.75x
Debt/Equity (TTM)	0.00x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	1.05
52W Performance	330.5%	62.2%
YTD Performance	232.7%	4.8%
% from 52W High	-12.2%	-23.1%
% from 52W Low	356.4%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.12x
FCF Yield (TTM)	2.6%	-15.5%
Earnings Yield (TTM)	3.4%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	-461.3
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View RCUS research

Valuation

P/E Ratio

CDNA

30.64x

P/S Ratio

CDNA

7.18x

RCUS

26.24x

EV/FCF

RCUS

-6.36x

CDNA

34.70x

Growth & revenue

Revenue Growth TTM

CDNA

34.4%

RCUS

-55.3%

Forward Revenue Growth

CDNA

7.0%

RCUS

-34.4%

Profitability & performance

Gross Margin

CDNA

70.6%

RCUS

0.0%

ROE

CDNA

32.8%

RCUS

-8954.0%

FCF Yield %

CDNA

2.6%

RCUS

-15.5%

52-Week Performance

CDNA

330.5%

RCUS

62.2%

Detailed metrics comparison

CDNA

CareDx Inc

RCUS

Arcus Biosciences Inc

Market Cap

CDNA$3.29B

RCUS$3.07B

Enterprise Value

CDNA$2.92B

RCUS$3.02B

Price

CDNA$63.67

RCUS$24.41

P/E Ratio

CDNA30.64x

RCUSN/A

P/S Ratio

CDNA7.18x

RCUS26.24x

EV/Sales

CDNA6.36x

RCUS25.82x

EV/EBITDA

CDNA23.24x

RCUS37.63x

P/B Ratio

CDNA8.16x

RCUS6.71x

P/FCF Ratio

CDNA39.14x

RCUSN/A

EV/FCF

CDNA34.70x

RCUS-6.36x

PEG Ratio

CDNA0.31x

RCUSN/A

Forward P/E (NTM)

CDNA57.50x

RCUSN/A

Forward P/S (NTM)

CDNA6.55x

RCUS84.08x

Revenue (TTM)

CDNA$458M

RCUS$117M

Revenue Growth (YoY)

CDNA34.4%

RCUS-55.3%

Forward Rev Growth

CDNA7.0%

RCUS-34.4%

Gross Margin (TTM)

CDNA70.6%

RCUS0.0%

Operating Margin (TTM)

CDNA23.6%

RCUS0.0%

EBITDA Margin (TTM)

CDNA27.4%

RCUS-406.8%

Net Margin (TTM)

CDNA24.2%

RCUS-393.2%

FCF Margin (TTM)

CDNA18.3%

RCUS-406.0%

Net Income (TTM)

CDNA$111M

RCUS$-460M

FCF (TTM)

CDNA$84M

RCUS$-475M

EPS (TTM)

CDNA$2.08

RCUS-$3.65

ROE (TTM)

CDNA32.8%

RCUS-8954.0%

ROA (TTM)

CDNA24.8%

RCUS-4561.0%

ROIC (TTM)

CDNA32.8%

RCUS-7501.0%

Cash

CDNA$374M

RCUS$150M

Debt

CDNA$0

RCUS$101M

Net Cash/Debt

CDNA$374M

RCUS$49M

Current Ratio (TTM)

CDNA4.58x

RCUS3.82x

Quick Ratio (TTM)

CDNA4.35x

RCUS3.75x

Debt/Equity (TTM)

CDNA0.00x

RCUS0.22x

Debt/Assets (TTM)

CDNA0.0%

RCUS0.0%

Interest Coverage (TTM)

CDNAN/A

RCUSN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

RCUS0.00x

Beta

CDNA2.58

RCUS1.05

52W Performance

CDNA330.5%

RCUS62.2%

YTD Performance

CDNA232.7%

RCUS4.8%

% from 52W High

CDNA-12.2%

RCUS-23.1%

% from 52W Low

CDNA356.4%

RCUS71.2%

Asset Turnover (TTM)

CDNA1.02x

RCUS0.12x

FCF Yield (TTM)

CDNA2.6%

RCUS-15.5%

Earnings Yield (TTM)

CDNA3.4%

RCUS-15.0%

Dividend Yield (TTM)

CDNAN/A

RCUSN/A

Rule of 40

CDNA52.7

RCUS-461.3

EV/GP/RG

CDNA0.94

RCUSN/A

Ticker research

View CDNA research View RCUS research

Metric	CDNA CareDx Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.29B	$3.07B
Enterprise Value	$2.92B	$3.02B
Price	$63.67	$24.41
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	26.24x
EV/Sales	6.36x	25.82x
EV/EBITDA	23.24x	37.63x
P/B Ratio	8.16x	6.71x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-6.36x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	N/A
Forward P/S (NTM)	6.55x	84.08x
Revenue & Growth
Revenue (TTM)	$458M	$117M
Revenue Growth (YoY)	34.4%	-55.3%
Forward Rev Growth	7.0%	-34.4%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-406.8%
Net Margin (TTM)	24.2%	-393.2%
FCF Margin (TTM)	18.3%	-406.0%
Net Income (TTM)	$111M	$-460M
FCF (TTM)	$84M	$-475M
EPS (TTM)	$2.08	-$3.65
ROE (TTM)	32.8%	-8954.0%
ROA (TTM)	24.8%	-4561.0%
ROIC (TTM)	32.8%	-7501.0%
Financial Health
Cash	$374M	$150M
Debt	$0	$101M
Net Cash/Debt	$374M	$49M
Current Ratio (TTM)	4.58x	3.82x
Quick Ratio (TTM)	4.35x	3.75x
Debt/Equity (TTM)	0.00x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	1.05
52W Performance	330.5%	62.2%
YTD Performance	232.7%	4.8%
% from 52W High	-12.2%	-23.1%
% from 52W Low	356.4%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.12x
FCF Yield (TTM)	2.6%	-15.5%
Earnings Yield (TTM)	3.4%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	-461.3
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View RCUS research